BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 9, 2009
View Archived Issues
Merck KGaA presents novel PDK1 inhibitors with oncolytic properties
Read More
Novel gamma-secretase inhibitors patented by Schering-Plough for treating Alzheimer's disease
Read More
New orexin receptor antagonists imparted by GSK for sleep disorders
Read More
Cyclopamine blocks serous ovarian tumor growth in vivo
Read More
U.S. Department of Health & Human Services divulges new antibacterial PSMalpha peptides
Read More
Oramed completes proof-of-concept study of ORMD-0802
Read More
EGEN-001 with chemotherapy shows activity in ovarian cancer
Read More
Fourth quarter highlights at AstraZeneca
Read More
ImClone continues development of arylphthalazine VEGFR-2 inhibitors
Read More
Cell-based gene therapy effective in SCID due to ADA deficiency
Read More
Fujifilm raises equity stake in Perseus Proteomics to focus on antibody-based therapeutics
Read More
Esteve Teijin Healthcare: A new venture to improve home respiratory therapy
Read More
PharmaMar receives Swiss approval for Yondelis in soft tissue sarcoma
Read More
Tibotec seeks traditional approval from FDA for Intelence
Read More
Cyclacel advances sapacitabine pivotal trial plan in hematological malignancies
Read More
Idenix and GlaxoSmithKline sign worldwide license agreement for IDX-899
Read More
FDA accepts for review NDA for intranasal ROX-888
Read More
Johnson & Johnson presents an update on Invega and paliperidone palmitate
Read More
Tigris files IND for anticancer drug GGTI-2418
Read More
FDA approves ATryn to prevent thromboembolic events
Read More
Nplate approved in the E.U. for the treatment of ITP
Read More
Orexo enters into exclusive development agreement for its OX-17 program
Read More
Daiichi Sankyo returns U.S. and European marketing rights for Collategene to AnGes
Read More
Bayer Schering initiates CHEST-1 and PATENT-1 phase III clinical trials of riociguat
Read More
Inhibitors of HIV reverse transcriptase under development at Yale University
Read More
